Anand Mehra - Nov 19, 2024 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Role
Director
Signature
/s/ Matthew Rothman, Attorney-in-Fact
Stock symbol
ACRS
Transactions as of
Nov 19, 2024
Transactions value $
$1,499,999
Form type
4
Date filed
11/20/2024, 04:20 PM
Previous filing
Jun 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Purchase $1.5M +667K +1537.37% $2.25 710K Nov 19, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock of the Issuer acquired from the Issuer pursuant to Rule 16b-3(d).